Φορτώνει......
Leveraging Genomic Data in Smoking Cessation Trials in the Era of Precision Medicine: Why and How
In an era of Precision Medicine, it is vital to collect biological data within clinical trials and to integrate their analysis within the outcomes of the trial. The identification of genomic biomarkers that affect treatment response to smoking cessation treatment, both pharmacological and behavioral...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Nicotine Tob Res |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Oxford University Press
2018
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5896450/ https://ncbi.nlm.nih.gov/pubmed/28498934 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ntr/ntx097 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|